1-6 of 6
Weiwei Zhu
Close
Sort by
Journal Articles

Does Provider Experience Treating Patients (pts) with Myelodysplastic Syndromes (MDS) Explain Duration of Hypomethylating Agent (HMA) Therapy and Overall Survival (OS)? A Large Population-Based Analysis

Amer M. Zeidan, MBBS, MHS, Xin Hu, MS, Weiwei Zhu, MPH, Maximilian Stahl, MD, Smith Giri, MBBS, Scott F Huntington, MDMPH, Rong Wang, PhD, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Amy J. Davidoff, PhD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 370.
https://doi.org/10.1182/blood-2018-99-111052
Published: 2018
Journal Articles

Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility

Scott F Huntington, MD MPH, Weiwei Zhu, MPH, Jessica Hoag, PhD, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Smith Giri, MBBS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Cary P Gross, MD, Amy J. Davidoff, PhD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 3538.
https://doi.org/10.1182/blood-2018-99-115140
Published: 2018
Journal Articles

Transfusion Independence in Lower-Risk, Non-del5(q) Myelodysplastic Syndromes (LR-MDS) Among Patients (pts) Initiating Hypomethylating Agents (HMAs) While Receiving Red Blood Cell (RBC) Transfusions

Amer M. Zeidan, MBBS, MHS, Weiwei Zhu, MPH, Rong Wang, PhD, Maximilian Stahl, MD, Scott F Huntington, MDMPH, Smith Giri, MBBS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Amy J. Davidoff, PhD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 838.
https://doi.org/10.1182/blood-2018-99-116497
Published: 2018
Journal Articles

Racial Disparities in the Utilization of Recommended Supportive Care Among Patients with Multiple Myeloma in the United States

Smith Giri, MBBS, Weiwei Zhu, MPH, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD MS, Scott F Huntington, MDMPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 978.
https://doi.org/10.1182/blood-2018-99-119791
Published: 2018
Journal Articles

Financial Incentives and Rituximab Maintenance: Association of Treatment Location with Prolonged Maintenance in Non-Hodgkin Lymphoma Patients Treated in the United States

Scott Huntington, MDMPH, Jessica Hoag, PhD, Weiwei Zhu, Ms, Cary P Gross, MD, Amy J. Davidoff, PhD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 2120.
https://doi.org/10.1182/blood.V130.Suppl_1.2120.2120
Published: 2017
Journal Articles

Hypoalbuminemia (< 3.0 g/dl) and Poor Karnofsky Performance Score (<80) at Day 90 Following Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT) Are Independent Predictors of Worse Non-Relapse Survival (NRS) and Overall Survival (OS): A Multivariable Analysis Approach of Various Clinical, Laboratory and Pharmacologic Parameters

Mohamed A Kharfan-Dabaja, MD, Julio C. Chavez, Eduardo Ivan Fernandez-Vertiz, Daohai Yu, Weiwei Zhu, Janelle Perkins, Teresa Field, Ernesto Ayala, Hugo F. Fernandez, Melissa Alsina, Lia Perez, Jyotishankar Raychaudhuri, J. Leonel Ochoa-Bayona, Linda Brand, Dan Sullivan, Claudio Anasetti
Journal: Blood
Blood (2008) 112 (11): 4329.
https://doi.org/10.1182/blood.V112.11.4329.4329
Published: 2008